In addition to Delta-9 THC, there is another phytochemical in marijuana called Delta 8 Tetrahydrocannabinol, or CBD for short, this phytochemical has the same chemical composition as THC but has a longer half-life than THC. Some studies have shown that it may help eliminate stomach problems in cancer patients because it stimulates creativity and reduces pain.
People have reported feeling a clear-headed high after taking wholesale delta 8 THC. However, it is essential to note that these feelings are very short-lived, only lasting from a few hours to a few days. Because of this, some people believe that it is simply a placebo effect, as people may feel a sensation of a “clear-headed high” after taking delta-8 THC but then be left feeling tired and lacking energy over the day much like a “crash” if they take alcohol. Nonetheless, for those who need a higher dosage of cannabis to relieve chronic pain or other symptoms of illness or use it regularly, it may very well be a viable option.
Delta 8 For Cancer Patients
For cancer patients undergoing chemotherapy, taking delta-8 THC may cause the cancer patient to positively respond to their treatment and reduce the intensity of some side effects, such as nausea and pain. It is less harmful than other anti-cancer drugs when administered with other anti-cancer medications, such as doxorubicin, vincristine, and docetaxel. For cancer patients who are currently undergoing chemotherapy, it has been noted that if delta-8 THC is combined with an anti-tumor agent, it can help chemotherapy patients treat their cancer more effectively. Most patients don’t like smoking anything in general, so unless they have a pre-existing condition like diabetes, they buy bulk delta 8 gummies that lasts them for at least a month or two.
The health benefits of delta 8 THC are well known. For example, it has been used to help people with certain medical conditions that affect their appetite. Delta-9 tetrahydrocannabinol, or THC, has been shown to reduce hunger and increase energy, making it very popular with weight loss and dieters. Fewer anxiety symptoms have also been identified as being associated with the plant, making it an effective appetite suppressant.
However, some researchers are concerned about the short-term use of marijuana. People who take it for a long time may develop addiction and substance abuse problems. It is this long-term use that has caught the attention of the medical community. Recent studies on animals indicate that marijuana has similar neuroprotective properties as that of the psychoactive metabolite THC. This compound seems to mimic the effect of the cannabis compound THC. The concern is that it might be responsible for the onset of schizophrenia and other types of schizophrenia-related behaviors.
Research About D8’s Toxicity
The latest research indicates that delta-8 THC has much lower toxicity than the psychoactive effects of THC. It has similar inflammatory and neuroprotective properties to psychoactive substances. Simonsohn et al. (Simonsohn and colleagues) examined the impact of two major groups of naturally occurring plant chemicals, namely, THC and CB1 receptors. They found that when mice were pretreated with chronic stress, they had higher levels of cb1 receptors in their brains than when they were healthy. Also, when these same mice were pretreated with chronic mild pain, they had lower cb1 receptor densities than when they were not in pain.
The scientists believe that the increase in CB1 receptors is the reason for the pain-relieving effect of the psychoactive effects of THC and CBD. Nevertheless, interestingly, these same researchers showed that mice treated with chronic stress had lower CB1 receptor densities than when they were healthy. The study by Simonsohn and colleagues is critical because it shows how much work lies behind the traditional view that only a few specific compounds work at a molecular level to produce the positive side-effects of THC and CBD. This effect is an essential first step toward understanding how the body forms a mosaic of chemical structures that help regulate mood, appetite, and sleep, among other things. It may also be an essential step toward developing a nonaddictive synthetic form of marijuana.
The latest study also indicates that the plant compounds that work at CB1 and CB2 receptors may also improve memory. The two molecules are thought to act in conjunction to improve the functioning of both the brain’s nerve cells and synapses, allowing us to process information and function. The discovery that CBD has this effect on the brain’s nerve cells opens up a possible route for the development of medical marijuana, although the exact mechanism by which it works is not known. For now, the focus will be on reducing nausea and other side-effects associated with chemotherapy and other cancer treatments and exploring the health benefits of THC and CBD for use as a natural alternative to chemotherapy and other drugs.
However, the latest study is not suggesting that we will soon offer medical marijuana to chronic sufferers of cancer or other disease symptoms. Although the scientists found that the two compounds, THC and CBD, had similar effects on mice, it is unclear whether their positive impact on CB1 and CB2 receptors will be the same for humans. In addition, the amount of CBD present in each marijuana plant can vary, depending on the variety grown. Therefore, until medical science can develop a standardized formula for increasing the levels of THC and CBD in food, it may be some time before medical marijuana becomes available for sale to those who need it for symptom relief. However, the health benefits of THC and CBD for weight loss, appetite suppression, and anxiety are clear.
The health benefits of delta 8 THC and CBD have clinical significance in treating debilitating medical conditions like cancer and HIV/AIDS or symptoms of those diseases. As a result, researchers are not recommending using these oils to treat common childhood ailments like headaches, fever, upset stomachs, or symptoms of depression and anxiety, or even as a simple appetite suppressant. Nevertheless, the prospect of reducing or eliminating the long-term side effects of chemotherapy and other medications is enough to encourage some researchers to continue their studies. If they find success, it is possible that medical marijuana may one day be readily available to people with chronic diseases and that CBD would also become a standard treatment for common psychological disorders.
The latest study indicates that CBD may not be effective when low doses of THC are combined with CBD. If this is true, it will be necessary to characterize CBD and THC further to determine whether they are beneficial. It is currently not known whether the beneficial effects of CBD are due to the presence of other compounds or the presence of the two ligands. However, the research indicates that future clinical trials should investigate the effect of delta-9-THC and CBD in combination, examining the health benefits for chronic disease patients and optimizing the use of these drugs for short-term management of chronic pain and other symptoms.